described is a method for isolating multiple blood products from a single starting material . isolation of multiple blood products from a single starting material maximizes the efficiency of blood product isolation . in the present invention , one or more blood products are isolated from a blood product material previously depleted of inter - alpha inhibitor protein . this method provides new paths for increasing the efficiency of isolating blood components and providing pharmaceutically acceptable forms of those components .